Täuber M G, Doroshow C A, Hackbarth C J, Rusnak M G, Drake T A, Sande M A
J Infect Dis. 1984 Apr;149(4):568-74. doi: 10.1093/infdis/149.4.568.
In order to define the characteristics of the antibacterial activity of beta-lactam antibiotics in the treatment of bacterial meningitis, the relationship between cerebrospinal fluid (CSF) drug concentrations and the rate of bacterial killing was investigated for penicillin G and four new cephalosporins in an animal model of meningitis due to Streptococcus pneumoniae. All five drugs showed a significant correlation between increasing drug concentrations in CSF and increasing bactericidal rates. Minimal activity was observed in CSF at drug concentrations of approximately the broth minimal bactericidal concentration (MBC). Maximal activity occurred with CSF concentrations 10-30 times higher. In vitro tests did not reproduce the unique correlation of increasing drug concentrations and killing activity found in vivo. When evaluating new beta-lactam antibiotics for the treatment of bacterial meningitis, it is reasonable to establish a minimum standard of CSF drug concentrations of greater than or equal to 30 times the MBC against the infecting organism.
为了明确β-内酰胺类抗生素在治疗细菌性脑膜炎时抗菌活性的特点,在肺炎链球菌所致脑膜炎的动物模型中,研究了青霉素G和四种新型头孢菌素的脑脊液(CSF)药物浓度与细菌杀灭率之间的关系。所有五种药物均显示CSF中药物浓度升高与杀菌率升高之间存在显著相关性。在药物浓度约为肉汤最低杀菌浓度(MBC)时,CSF中观察到最小活性。当CSF浓度高出10 - 30倍时,出现最大活性。体外试验未能重现体内发现的药物浓度升高与杀灭活性之间的独特相关性。在评估用于治疗细菌性脑膜炎的新型β-内酰胺类抗生素时,确定CSF药物浓度的最低标准为大于或等于针对感染病原体的MBC的30倍是合理的。